Intestinal Research

Concomitant ankylosing spondylitis can increase the risk of biologics or small molecule therapies to control inflammatory bowel disease: Yu Kyung Jun, Hyuk Yoon, Seong-Joon Koh, A Hyeon Kim, Kwang Woo Kim, Jun Won Park, Hyun Jung Lee, Hyoun Woo Kang, Jong Pil Im, Young Soo Park, Joo Sung Kim, on behalf of Seoul National University Inflammatory Bowel Disease Research Network (SIRN); Received April 22, 2022 Accepted June 10, 2022; DOI: https://doi.org/10.5217/ir.2022.00057 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Proposal of novel staging system CNM (Crohn’s primary site, nodes, mesentery) to predict postoperative recurrence of Crohn’s disease: Guduru Venkat Rao, Partha Pal, Anuradha Sekaran, Pradeep Rebala, Manu Tandan, D. Nageshwar Reddy; Received April 1, 2022 Accepted June 6, 2022; DOI: https://doi.org/10.5217/ir.2022.00045 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF

Abdominal aortic calcification in patients with inflammatory bowel disease: does anti-tumor necrosis factor α use protect from chronic inflammation-induced atherosclerosis?: Aikaterini Mantaka, Nikolaos Galanakis, Dimitrios Tsetis, Ioannis E. Koutroubakis; Received February 6, 2022 Accepted May 12, 2022; DOI: https://doi.org/10.5217/ir.2022.00017 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF

Clinical spectrum of elderly-onset inflammatory bowel disease in India: Yogesh Kumar Gupta, Arshdeep Singh, Vikram Narang, Vandana Midha, Ramit Mahajan, Varun Mehta, Dharmatma Singh, Namita Bansal, Madeline Vithya Barnaba Durairaj, Amit Kumar Dutta, Ajit Sood; Received December 27, 2021 Accepted May 17, 2022; DOI: https://doi.org/10.5217/ir.2021.00177 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF

Urinary chitinase 3-like 1 and intestinal fatty-acid binding proteins are not elevated in children with inflammatory bowel disease: Shaun Siong Chung Ho, Jacqueline Ilene Keenan, Andrew Stewart Day; Received May 6, 2022 Accepted July 1, 2022; DOI: https://doi.org/10.5217/ir.2022.00064 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF

Characteristics and usefulness of transabdominal ultrasonography in immune-mediated colitis: Kensuke Sakurai, Takehiko Katsurada, Mutsumi Nishida, Satomi Omotehara, Shinya Fukushima, Shinsuke Otagiri, Kazunori Nagashima, Reizo Onishi, Ryo Takagi, Yoshito Komatsu, Naoya Sakamoto; Received December 3, 2021 Accepted June 6, 2022; DOI: https://doi.org/10.5217/ir.2021.00166 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Real-world effectiveness and safety of ustekinumab induction therapy for Korean patients with Crohn’s disease: a KASID prospective multicenter study: Kyunghwan Oh, Hee Seung Hong, Nam Seok Ham, Jungbok Lee, Sang Hyoung Park, Suk-Kyun Yang, Hyuk Yoon, You Sun Kim, Chang Hwan Choi, Byong Duk Ye, on behalf of the Korean Association for the Study of Intestinal Diseases; Received December 23, 2021 Accepted February 14, 2022; DOI: https://doi.org/10.5217/ir.2021.00173 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF

Reviewing not Homer’s Iliad, but “Kai Bao Ben Cao”: indigo dye—the past, present, and future: Yusuke Yoshimatsu, Tomohisa Sujino, Takanori Kanai; Received February 7, 2022 Accepted April 23, 2022; DOI: https://doi.org/10.5217/ir.2022.00018 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF

Compositional changes in fecal microbiota associated with clinical phenotypes and prognosis in Korean patients with inflammatory bowel disease: Seung Yong Shin, Young Kim, Won-Seok Kim, Jung Min Moon, Kang-Moon Lee, Sung-Ae Jung, Hyesook Park, Eun Young Huh, Byung Chang Kim, Soo Chan Lee, Chang Hwan Choi, on behalf of the IBD Research Group of the Korean Association for the Study of Intestinal Diseases; Received December 10, 2021 Accepted March 10, 2022; DOI: https://doi.org/10.5217/ir.2021.00168 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Interferon-gamma release assay has poor diagnostic accuracy in differentiating intestinal tuberculosis from Crohn’s disease in tuberculosis endemic areas: Karan Sachdeva, Peeyush Kumar, Bhaskar Kante, Sudheer K. Vuyyuru, Srikant Mohta, Mukesh K. Ranjan, Mukesh K. Singh, Mahak Verma, Govind Makharia, Saurabh Kedia, Vineet Ahuja; Received January 18, 2022 Accepted March 27, 2022; DOI: https://doi.org/10.5217/ir.2022.00010 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF

Clinical features of very early-onset inflammatory bowel disease in Japan: a retrospective single-center study: Masaaki Usami, Ichiro Takeuchi, Reiko Kyodo, Yuri Hirano, Kosuke Kashiwagi, Hiroki Fujikawa, Hirotaka Shimizu, Toshinao Kawai, Katsuhiro Arai; Received October 20, 2021 Accepted April 6, 2022; DOI: https://doi.org/10.5217/ir.2021.00142 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF

Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis: Soo-Young Na, Chang Hwan Choi, Eun Mi Song, Ki Bae Bang, Sang Hyoung Park, Eun Soo Kim, Jae Jun Park, Bora Keum, Chang Kyun Lee, Bo-In Lee, Seung-Bum Ryoo, Seong-Joon Koh, Miyoung Choi, Joo Sung Kim, On behalf of the IBD Research Group of the Korean Association for the Study of Intestinal Diseases; Received January 16, 2021 Accepted March 7, 2022; DOI: https://doi.org/10.5217/ir.2022.00007 [Epub ahead of print]
Cited By 1; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Involvement of the cannabinoid system in chronic inflammatory intestinal diseases: opportunities for new therapies: Priscila A. Lima, Bárbara B. Berg, Marina Gomes Miranda e Castor; Received November 19, 2021 Accepted March 16, 2022; DOI: https://doi.org/10.5217/ir.2021.00160 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF

An Asian perspective on irritable bowel syndrome: Kee Wook Jung, Seung-Jae Myung; Received October 5, 2021 Accepted January 16, 2022; DOI: https://doi.org/10.5217/ir.2021.00136 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF

Novel inflammatory bowel disease (IBD) specific electronic medical record allows scalable auditing of IBD severity, therapy and complications to show the current unmet need in IBD care: Alex Barnes, David Carter, Patricia Kaazan, Alissa Walsh, Susan Connor, Jane M Andrews; Received January 4, 2022 Accepted March 23, 2022; DOI: https://doi.org/10.5217/ir.2022.00003 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF

The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitis: Jae Hee Cheon, Kristine Paridaens, Sameer Al Awadhi, Jakob Begun, John R Fullarton, Edouard Louis, Fernando Magro, Juan Ricardo Marquez, Alexander R Moschen, Neeraj Narula, Grazyna Rydzewska, Axel U Dignass, Simon PL Travis; Received January 10, 2022 Accepted March 16, 2022; DOI: https://doi.org/10.5217/ir.2022.00006 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Gastrointestinal bleeding risk of non-vitamin K antagonist oral anticoagulants versus warfarin in general and after polypectomy: a population-based study with propensity score matching analysis: Jong Yop Pae, Eun Soo Kim, Sung Kook Kim, Min Kyu Jung, Jun Heo, Jang Hoon Lee, Min Ae Park; Received November 25, 2021 Accepted March 16, 2022; DOI: https://doi.org/10.5217/ir.2021.00161 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Long-term clinical and real-world experience with Crohn’s disease treated with anti-tumor necrosis factor-α antibodies: Haruka Otake, Satohiro Matsumoto, Hirosato Mashima; Received October 9, 2021 Accepted January 26, 2022; DOI: https://doi.org/10.5217/ir.2021.00139 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF

Incidence rates for hospitalized infections, herpes zoster, and malignancies in patients with ulcerative colitis in Japan: an administrative health claims database analysis: Katsuyoshi Matsuoka, Kanae Togo, Noritoshi Yoshii, Masato Hoshi, Shoko Arai; Received November 3, 2021 Accepted January 17, 2022; DOI: https://doi.org/10.5217/ir.2021.00154 [Epub ahead of print]
Cited By 1; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Efficacy and safety of filgotinib as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a post-hoc analysis of the phase 2b/3 SELECTION trial: Toshifumi Hibi, Satoshi Motoya, Tadakazu Hisamatsu, Fumihito Hirai, Kenji Watanabe, Katsuyoshi Matsuoka, Masayuki Saruta, Taku Kobayashi, Brian G Feagan, Chantal Tasset, Robin Besuyen, Chohee Yun, Gerald Crans, Jie Zhang, Akira Kondo, Mamoru Watanabe; Received October 21, 2021 Accepted December 31, 2021; DOI: https://doi.org/10.5217/ir.2021.00143 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Physician education can minimize inappropriate steroid use in patients with inflammatory bowel disease: the ACTION study: Yehyun Park, Chang Hwan Choi, Hyun Soo Kim, Hee Seok Moon, Do Hyun Kim, Jin Ju Kim, Dennis Teng, Dong Il Park; Received September 21, 2021 Accepted November 25, 2021; DOI: https://doi.org/10.5217/ir.2021.00125 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Efficacy of hepatitis B vaccination in patients with ulcerative colitis: a prospective cohort study: Anurag Mishra, Amarender Singh Puri, Sanjeev Sachdeva, Ashok Dalal; Received July 29, 2021 Accepted October 8, 2021; DOI: https://doi.org/10.5217/ir.2021.00106 [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF

Korean Association for the Study of Intestinal Diseases guidance for clinical practice of adult inflammatory bowel disease during the coronavirus disease 2019 pandemic: expert consensus statements: Yong Eun Park, Yoo Jin Lee, Ji Young Chang, Hyun Joo Song, Duk Hwan Kim, Young Joo Yang, Byung Chang Kim, Jae Gon Lee, Hee Chan Yang, Miyoung Choi, Seong-Eun Kim, Seung-Jae Myung; Received August 8, 2021 Accepted September 9, 2021; DOI: https://doi.org/10.5217/ir.2021.00111 [Epub ahead of print]
Cited By 1; Full text PubReader ePub Crossref - TDM PDF

Natural history of inflammatory bowel disease: a comparison between the East and the West: Eun Mi Song, Suk-Kyun Yang; Received July 28, 2021 Accepted September 20, 2021; DOI: https://doi.org/10.5217/ir.2021.00104 [Epub ahead of print]
Cited By 8; Full text PubReader ePub Crossref - TDM PDF

Ahead-of Print